RadNet, Inc. (RDNT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 697.82M USD | Liabilities, Current |
| Cash and equivalents | 726.27M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 241.84M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $697.82M | $726.27M | (m) | $241.84M | (m) | (m) |
| 2026-03-31 | (m) | $635.63M | $455.34M | (m) | $209.09M | (m) | (m) |
| 2025-12-31 | (m) | $586.76M | $767.22M | (m) | $200.32M | (m) | (m) |
| 2025-09-30 | (m) | $574.91M | $804.72M | (m) | $210.55M | (m) | (m) |
| 2025-06-30 | (m) | $546.21M | $833.15M | (m) | $199.99M | (m) | (m) |
| 2025-03-31 | (m) | $505.40M | $717.32M | (m) | $200.13M | (m) | (m) |
| 2024-12-31 | (m) | $479.71M | $740.02M | (m) | $185.82M | (m) | (m) |
| 2024-09-30 | (m) | $470.13M | $748.92M | (m) | $199.08M | (m) | (m) |
| 2024-06-30 | (m) | $474.20M | $741.68M | (m) | $195.29M | (m) | (m) |
| 2024-03-31 | (m) | $427.89M | $526.98M | (m) | $189.57M | (m) | (m) |
| 2023-12-31 | (m) | $437.45M | $342.57M | (m) | $163.71M | (m) | (m) |
| 2023-09-30 | (m) | $407.08M | $337.88M | (m) | $167.74M | (m) | (m) |
| 2023-06-30 | (m) | $434.23M | $356.65M | (m) | $174.48M | (m) | (m) |
| 2023-03-31 | (m) | $407.14M | $90.84M | (m) | $176.35M | (m) | (m) |
| 2022-12-31 | (m) | $466.72M | $127.83M | (m) | $166.36M | (m) | (m) |
| 2022-09-30 | (m) | $409.22M | $95.01M | (m) | $172.51M | (m) | (m) |
| 2022-06-30 | (m) | $404.52M | $99.17M | (m) | $166.39M | (m) | (m) |
| 2022-03-31 | (m) | $381.30M | $70.71M | (m) | $159.72M | (m) | (m) |
| 2021-12-31 | (m) | $374.78M | $134.61M | (m) | $135.06M | (m) | (m) |
| 2021-09-30 | (m) | $371.50M | $151.25M | (m) | $152.41M | (m) | (m) |
| 2021-06-30 | (m) | $381.27M | $140.85M | (m) | $157.33M | (m) | (m) |
| 2021-03-31 | (m) | $402.62M | $31.09M | (m) | $146.66M | (m) | (m) |
| 2020-12-31 | (m) | $398.11M | $102.02M | (m) | $129.59M | (m) | (m) |
| 2020-09-30 | (m) | $373.79M | $89.74M | (m) | $137.41M | (m) | (m) |
| 2020-06-30 | (m) | $382.39M | $84.58M | (m) | $125.75M | (m) | (m) |
| 2020-03-31 | (m) | $327.99M | $94.28M | (m) | $144.26M | (m) | (m) |
| 2019-12-31 | (m) | $327.43M | $40.16M | (m) | $154.76M | (m) | (m) |
| 2019-09-30 | (m) | $309.52M | $37.69M | (m) | $150.75M | (m) | (m) |
| 2019-06-30 | (m) | $293.25M | $30.50M | (m) | $159.32M | (m) | (m) |
| 2019-03-31 | (m) | $300.59M | $10.43M | (m) | $156.77M | (m) | (m) |
| 2018-12-31 | (m) | $239.52M | $10.39M | (m) | $148.92M | (m) | (m) |
| 2018-09-30 | (m) | $203.39M | $27.23M | (m) | $156.40M | (m) | (m) |
| 2018-06-30 | (m) | $193.97M | $16.25M | (m) | $152.17M | (m) | (m) |
| 2018-03-31 | (m) | $204.86M | $35.04M | (m) | $161.65M | (m) | (m) |
| 2017-12-31 | (m) | $191.61M | $51.32M | (m) | $155.52M | (m) | (m) |
| 2017-09-30 | (m) | $156.75M | $8.47M | (m) | $168.59M | (m) | (m) |
| 2017-06-30 | (m) | $151.80M | $12.71M | (m) | $170.16M | (m) | (m) |
| 2017-03-31 | (m) | $158.93M | $8.29M | (m) | $169.54M | (m) | (m) |
| 2016-12-31 | (m) | $155.34M | $20.64M | (m) | $164.21M | (m) | (m) |
| 2016-09-30 | (m) | $152.57M | $358.00K | (m) | $183.23M | (m) | (m) |
| 2016-06-30 | (m) | $150.09M | $433.00K | (m) | $165.09M | (m) | (m) |
| 2016-03-31 | (m) | $154.51M | $410.00K | (m) | $177.83M | (m) | (m) |
| 2015-12-31 | (m) | $157.65M | $446.00K | (m) | $162.84M | (m) | (m) |
| 2015-09-30 | (m) | $136.50M | $36.05M | (m) | $159.21M | (m) | (m) |
| 2015-06-30 | (m) | $128.34M | $5.32M | (m) | $155.96M | (m) | (m) |
| 2015-03-31 | (m) | $132.66M | $154.00K | (m) | $153.26M | (m) | (m) |
| 2014-12-31 | (m) | $133.27M | $307.00K | (m) | $148.24M | (m) | (m) |
| 2014-09-30 | (m) | $131.52M | $274.00K | (m) | $155.01M | (m) | (m) |
| 2014-06-30 | (m) | $127.61M | $831.00K | (m) | $147.02M | (m) | (m) |
| 2014-03-31 | (m) | $121.48M | $291.00K | (m) | $140.63M | (m) | (m) |
| 2013-12-31 | (m) | $118.39M | $8.41M | (m) | $133.60M | (m) | (m) |
| 2013-09-30 | (m) | $111.44M | $268.00K | (m) | $134.26M | (m) | (m) |
| 2013-06-30 | (m) | $120.44M | $251.00K | (m) | $139.37M | (m) | (m) |
| 2013-03-31 | (m) | $125.20M | $431.00K | (m) | $134.94M | (m) | (m) |
| 2012-12-31 | (m) | $118.61M | $362.00K | (m) | $129.19M | (m) | (m) |
| 2012-09-30 | (m) | $117.93M | $388.00K | (m) | $128.64M | (m) | (m) |
| 2012-06-30 | (m) | $126.44M | $234.00K | (m) | $131.44M | (m) | (m) |
| 2012-03-31 | (m) | $128.18M | $1.83M | (m) | $133.97M | (m) | (m) |
| 2011-12-31 | (m) | $122.38M | $2.46M | (m) | $128.43M | (m) | (m) |
| 2011-09-30 | (m) | $109.42M | $254.00K | (m) | $122.04M | (m) | (m) |
| 2011-06-30 | (m) | $111.93M | $178.00K | (m) | $116.90M | (m) | (m) |
| 2011-03-31 | (m) | (m) | $259.00K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $105.26M | $627.00K | (m) | $96.09M | (m) | (m) |
| 2010-09-30 | (m) | (m) | $24.46M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $20.48M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $10.09M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |